ClinicalTrials.gov
public full text
Public Domain
Does Oral Pentoxifylline Administration Improve Hemoglobin in Hemodialysis Patients?
Our study investigated the effect of using a known drug used in intermittent claudication (named pentoxifylline) as an adjuvant to erythropoietin stimulating agents to improve anemia of hemodialysis patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pentoxifylline Administration in Hemodialysis Patients#1170869
- Pentoxifylline in Diabetic Kidney Disease#387291
- ICHARUS: Italian Cooperative HemoAdsorption Study for Relief of Uremic Symptoms#858673
- Aerobic Exercise During Hemodialysis#867682
- The Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of Evogliptin in Hemodialysis Patients#1150871
Record · ID 830048
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive